Christos Tzimas

  • Citations Per Year
Learn More
AIMS H2S is known to confer cardioprotection; however, the pathways mediating its effects in vivo remain incompletely understood. The purpose of the present study is to evaluate the contribution of cGMP-regulated pathways in the infarct-limiting effect of H2S in vivo. METHODS AND RESULTS Anaesthetized rabbits were subjected to myocardial ischaemia(More)
A number of genetic mutations is associated with cardiomyopathies. A mutation in the coding region of the phospholamban (PLN) gene (R14del) is identified in families with hereditary heart failure. Heterozygous patients exhibit left ventricular dilation and ventricular arrhythmias. Here we generate induced pluripotent stem cells (iPSCs) from a patient(More)
1Department of Pharmacology, Medical School, University of Athens, Greece 2Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Greece *Email: dsanoudou@bioacademy.gr INTRODUCTION The 21st century is considered by many as the era of genomic medicine. Indeed, fascinating advances have been achieved both in terms of(More)
It is well established that Notch functions as a transcriptional activator through the formation of a ternary complex that comprises Notch, Maml, and CSL. This ternary complex then serves to recruit additional transcriptional cofactors that link to higher order transcriptional complexes. The mechanistic details of these events remain unclear. This report(More)
Aims The histidine-rich calcium-binding protein (HRC) Ser96Ala variant has previously been identified as a potential biomarker for ventricular arrhythmias and sudden cardiac death in patients with idiopathic dilated cardiomyopathy. Herein, the role of this variant in cardiac pathophysiology is delineated through a novel mouse model, carrying the human(More)
  • 1